SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-008506
Filing Date
2021-04-12
Accepted
2021-04-12 12:09:03
Documents
14
Period of Report
2021-04-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 36455
2 ex10-1.htm EX-10.1 8416
3 ex99-1.htm EX-99.1 15996
4 ex10-1_001.jpg GRAPHIC 199394
5 ex10-1_002.jpg GRAPHIC 288527
6 ex10-1_003.jpg GRAPHIC 244989
7 ex10-1_004.jpg GRAPHIC 279294
8 ex10-1_005.jpg GRAPHIC 301626
9 ex10-1_006.jpg GRAPHIC 283480
10 ex10-1_007.jpg GRAPHIC 284507
11 ex10-1_008.jpg GRAPHIC 261558
12 ex10-1_009.jpg GRAPHIC 261968
13 ex10-1_010.jpg GRAPHIC 47198
14 ex10-1_011.jpg GRAPHIC 37746
  Complete submission text file 0001493152-21-008506.txt   3492955
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 21819965
SIC: 3674 Semiconductors & Related Devices